Tina S. Morris, PhD, is vice president of Biologics & Biotechnology at United States Pharmacopeia (USP)
US Pharmacopeia promotes horizontal standards and a product-class approach for quality attributes.
US Pharmacopeia develops and improves its class approach for ensuring quality biopharmaceuticals.
USP is advancing efforts to develop a guidance for evaluating bioassays.
Modern bioassays enable more accurate potency testing.